반응식
I[C:2]1[CH:3]=[C:4]([CH2:8][C@H:9]([NH:18][C:19](=[O:25])[O:20][C:21]([CH3:24])([CH3:23])[CH3:22])[C:10](=[O:17])[N:11]2[CH2:16][CH2:15][CH2:14][CH2:13][CH2:12]2)[CH:5]=[CH:6][CH:7]=1.[C:26]([O:32][C:33]([CH3:36])([CH3:35])[CH3:34])(=[O:31])[CH2:27][CH2:28][C:29]#[CH:30].C(N(CC)CC)C.C(Cl)Cl>CN(C=O)C.CCCCCC.C(OCC)(=O)C.[Cu]I.C1C=CC(P(C2C=CC=CC=2)[C-]2C=CC=C2)=CC=1.C1C=CC(P(C2C=CC=CC=2)[C-]2C=CC=C2)=CC=1.Cl[Pd]Cl.[Fe+2]>[C:21]([O:20][C:19]([NH:18][C@H:9]([C:10](=[O:17])[N:11]1[CH2:16][CH2:15][CH2:14][CH2:13][CH2:12]1)[CH2:8][C:4]1[CH:3]=[C:2]([C:30]#[C:29][CH2:28][CH2:27][C:26]([O:32][C:33]([CH3:36])([CH3:35])[CH3:34])=[O:31])[CH:7]=[CH:6][CH:5]=1)=[O:25])([CH3:24])([CH3:23])[CH3:22]참가 물질
반응물 4
생성물 1
시약·촉매·용매 4
실험 절차
tert-Butyl (S)-(3-(3-iodophenyl)-1-oxo-1-(piperidin-1-yl)propan-2-yl)carbamate (Compound SP418, Boc-Phe(3-I)-pip) (5.00 g, 10.91 mmol), tert-butyl pent-4-ynoate (3.36 g, 21.82 mmol) and triethylamine (4.56 ml, 32.7 mmol) were dissolved in DMF (50.0 ml), CuI (0.104 g, 0.545 mmol) and Pd(dppf)Cl2.CH2Cl2 (0.449 g, 0.545 mmol) were added and the mixture was stirred at room temperature for 5 hours. The reaction solution was diluted with hexane/ethyl acetate (1/1) and washed with a saturated aqueous ammonium chloride solution and brine. The organic layer was dried over anhydrous magnesium sulfate, and then filtered and concentrated under reduced pressure, and the resulting residue was purified by silica gel column chromatography (hexane:ethyl acetate=100:0-60:40) to afford the title compound (Compound SP430) (4.84 g, 92%).
후처리
- washwashed with a saturated aqueous ammonium chloride solution and brine
- dry with materialThe organic layer was dried over anhydrous magnesium sulfate
- filtrationfiltered
- concentrationconcentrated under reduced pressure
- customthe resulting residue was purified by silica gel column chromatography (hexane:ethyl acetate=100:0-60:40)
출처 및 근거
- ORD 기록
- ord-9e302d7ad16f48638b88abfe84ec7c12
- 출처 데이터셋
- uspto-grants-2016_08
- 특허 번호
- US09409952B2
연결된 노트
불러오는 중…